Streetbeat News

Regulatory

BGNE

BeiGene announced that the FDA has granted Fast Track Designation to its investigational drug BGB-16673 for treating relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma. This designation aims to expedite the drug's development and review process.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 10:02 am

EWJ

FXI

SPY

A Chinese military plane reportedly violated Japan's airspace, according to Japan's Kyodo News Agency, citing the Defense Ministry. This incident could heighten geopolitical tensions between China and Japan.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 9:19 am

BTCUSD

Authorities in Thailand uncovered an illegal Bitcoin mining operation linked to power outages. The operation consumed electricity without full payment, causing blackouts. This highlights the challenges of power-intensive Bitcoin mining, especially after the recent halving reduced miners' revenue.

Portfolio Pulse from Aniket Verma

August 26, 2024 | 9:00 am

UGRO

urban-gro has received a non-compliance notice from Nasdaq due to a delayed 10-Q filing. However, their listing status remains unaffected.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 7:46 am

RILY

B. Riley Financial has received a Nasdaq delinquency notice due to a delayed 10-Q filing. This could impact investor confidence and the company's stock price in the short term.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 7:40 am

CLRB

Cellectar Biosciences has announced a plan to restate its financials, delaying its 10-Q filing for the second quarter of 2024. Consequently, the company received a non-compliance notification from Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 7:38 am

SPY

The Federal Reserve is expected to cut interest rates in September due to weak economic data and improved pricing pressure. Historical patterns suggest that such rate cuts may not lead to sustained market rallies, as seen in 2001 and 2007. The SPDR S&P 500 ETF Trust (SPY) has gained 19% year-to-date, but the impact of the anticipated rate cut remains uncertain.

Portfolio Pulse from Shanthi Rexaline

August 26, 2024 | 7:26 am

ENTO

Entero Therapeutics has received a notification from Nasdaq regarding a delayed 10-Q filing. The company plans to regain compliance by the October deadline.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 7:20 am

PPSI

Pioneer Power Solutions has received a delinquency notification from Nasdaq due to delayed quarterly filings. This could impact the company's stock price as it may raise concerns about its financial reporting practices.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 6:55 am

IMAC

IMAC Holdings has received a Nasdaq deficiency notice due to a delayed filing of its quarterly report. The company has until October 20, 2024, to submit a compliance plan and may receive an extension until February 17, 2025, if accepted by Nasdaq.

Portfolio Pulse from Benzinga Newsdesk

August 26, 2024 | 6:45 am